N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine

This compound is an experimental small molecule with the chemical formula C22H23ClN6 and a molecular weight of approximately 406.9 g/mol. It belongs to the class of organoheterocyclic compounds known as imidazoquinoxalines. The drug has been identified in chemical and biological databases but does not have any approved medical indications or clinical trial data available. Mechanistically, it is known to interact with LCK proto-oncogene, Src family tyrosine kinase (LCK), suggesting potential activity as a kinase inhibitor; however, its precise mechanism of action and therapeutic applications remain uncharacterized in public sources[4][6][7]. The compound has been studied for possible effects on neurotransmitter systems in the brain but remains at an early stage of investigation without established clinical use[10].

Other names

N-(2-Chlor-6-methylphenyl)-8-[(3S)-3-methylpiperazinyl]imidazo[1,5-a]chinoxalin-4-aminoN-(2-Chloro-6-méthylphényl)-8-[ (3S ) - 3 - méthyl - 1 - pipérazinyle ] imidazo [ 1 , 5 - a ] quinoxaline - 4 - amine